At a glance
- Originator Toa Eiyo
- Class Anti-inflammatories; Antirheumatics
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 04 Nov 1994 Discontinued-Preclinical for Inflammation in Japan (Unknown route)